EAPIF (Euroapi) Total Long-Term Assets: $628.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EAPIF Euroapi SA EAPIF
52 GF Score
Price $1.51
GF Value $3.31
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Euroapi Total Long-Term Assets?

Euroapi EAPIF 52 Total Long-Term Assets is $628.0 Mil as of Dec. 2025. GuruFocus rates EAPIF with a GF Score™ of 52/100 and a GF Value™ of $3.31 (Possible Value Trap). The stock has 6 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Euroapi's Total Long-Term Assets for the quarter that ended in Dec. 2025 was $628.0 Mil.

Euroapi Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Euroapi's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euroapi Total Long-Term Assets Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial 810.17 754.66 690.62 690.47 627.99

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 690.62 689.02 690.47 755.36 627.99
EAPIF
52GF Score
Euroapi SA EAPIF
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euroapi Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of $628.0 Mil mean?
Euroapi (EAPIF) has a Total Long-Term Assets of $628.0 Mil as of Dec. 2025. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Euroapi and its competitors.
Is Euroapi's Total Long-Term Assets too high?
Euroapi's current Total Long-Term Assets is $628.0 Mil. Overall, Euroapi has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Euroapi's Total Long-Term Assets compare to ZTS and UTHR?
Euroapi's Total Long-Term Assets of $628.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Drug Manufacturers company?
A good Total Long-Term Assets depends on the Drug Manufacturers industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Euroapi and its competitors. Euroapi's current Total Long-Term Assets is $628.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euroapi stock overvalued right now?
Based on GuruFocus' analysis, Euroapi (EAPIF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.31, compared to a current price of $1.51 — trading 54.4% below its estimated fair value. The current Total Long-Term Assets is $628.0 Mil. Euroapi's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Euroapi (EAPIF), the current Total Long-Term Assets is $628.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euroapi (EAPIF) Overvalued in 2026?

Based on GuruFocus' analysis, Euroapi stock appears to be undervalued. The current stock price of $1.51 is trading 54.4% below its estimated GF Value™ of $3.31. GuruFocus considers Euroapi to be Possible Value Trap.

Key valuation signals for EAPIF:

  • Total Long-Term Assets: $628.0 Mil
  • GF Value™: $3.31 vs. price of $1.51 (54.4% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the EAPIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euroapi Business Description

Address 32 rue Alexandre Duma, Paris, FRA, 75011
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
52GF Score

Get the complete analysis for EAPIF

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.51
Price
$3.31
GF Value